Position in GALT
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$745,488
-$607,576 QoQ
Shares Held
267,200
-17.8% QoQ
Ownership
0.406%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LPL Financial LLC holds $467,195,563 across 201 Biotechnology names. GALT ranks #69 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
268,062 | $119,700,405 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
63,987 | $49,438,915 | |
| 3 | INSM |
INSMED Inc
|
138,281 | $22,611,709 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
67,637 | $22,379,054 | |
| 5 | EXEL |
Exelixis, Inc.
|
399,612 | $17,139,358 | |
| 6 | ARGX |
Argenx SE
|
23,247 | $16,976,121 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
194,304 | $12,557,867 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
378,656 | $10,488,771 |
All Filings in GALT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $745,488 | 267,200 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,353,064 | 325,256 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,527,536 | 360,268 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $774,323 | 366,978 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $236,043 | 193,478 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $179,217 | 138,928 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $225,247 | 81,908 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $197,203 | 87,258 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $131,598 | 55,062 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $86,007 | 51,812 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $99,479 | 51,812 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $74,609 | 51,812 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $109,855 | 52,312 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $70,707 | 62,573 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $101,178 | 62,073 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $76,679 | 58,534 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $94,239 | 58,534 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $98,602 | 47,634 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $192,191 | 49,534 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $166,508 | 52,034 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $35,336 | 16,284 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $39,388 | 17,584 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $49,619 | 18,584 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $86,392 | 28,233 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $51,961 | 26,511 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||